Table of Content

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Osteoporosis Drugs Market, by Route of Administration
1.4.2 Asia Pacific Osteoporosis Drugs Market, by Drug Class
1.4.3 Asia Pacific Osteoporosis Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Osteoporosis Drugs Market by Route of Administration
3.1 Asia Pacific Oral Market by Country
3.2 Asia Pacific Injectable Market by Country
3.3 Asia Pacific Other Route of Administration Market by Country
Chapter 4. Asia Pacific Osteoporosis Drugs Market by Drug Class
4.1 Asia Pacific Bisphosphonates Market by Country
4.2 Asia Pacific Rank Ligand Inhibitors Market by Country
4.3 Asia Pacific Parathyroid Hormone Therapy Market by Country
4.4 Asia Pacific Calcitonin Market by Country
4.5 Asia Pacific Other Drug Class Market by Country
Chapter 5. Asia Pacific Osteoporosis Drugs Market by Country
5.1 China Osteoporosis Drugs Market
5.1.1 China Osteoporosis Drugs Market by Route of Administration
5.1.2 China Osteoporosis Drugs Market by Drug Class
5.2 India Osteoporosis Drugs Market
5.2.1 India Osteoporosis Drugs Market by Route of Administration
5.2.2 India Osteoporosis Drugs Market by Drug Class
5.3 Japan Osteoporosis Drugs Market
5.3.1 Japan Osteoporosis Drugs Market by Route of Administration
5.3.2 Japan Osteoporosis Drugs Market by Drug Class
5.4 South Korea Osteoporosis Drugs Market
5.4.1 South Korea Osteoporosis Drugs Market by Route of Administration
5.4.2 South Korea Osteoporosis Drugs Market by Drug Class
5.5 Singapore Osteoporosis Drugs Market
5.5.1 Singapore Osteoporosis Drugs Market by Route of Administration
5.5.2 Singapore Osteoporosis Drugs Market by Drug Class
5.6 Malaysia Osteoporosis Drugs Market
5.6.1 Malaysia Osteoporosis Drugs Market by Route of Administration
5.6.2 Malaysia Osteoporosis Drugs Market by Drug Class
5.7 Rest of Asia Pacific Osteoporosis Drugs Market
5.7.1 Rest of Asia Pacific Osteoporosis Drugs Market by Route of Administration
5.7.2 Rest of Asia Pacific Osteoporosis Drugs Market by Drug Class
Chapter 6. Company Profiles
6.1 Amgen, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Research & Development Expense
6.1.4 Recent strategies and developments:
6.1.4.1 Partnerships, Collaborations, and Agreements:
6.1.4.2 Approvals:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 GlaxoSmithKline PLC (GSK)
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Merck & Co., Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.5 Novartis AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Recent strategies and developments:
6.5.4.1 Partnerships, Collaborations, and Agreements:
6.6 Pfizer, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Sun Pharmaceutical Industries Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expenses
6.9 Allergan PLC
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.1 Eli Lilly and Company
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expense



List of Tables


TABLE 1 ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 2 ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 3 ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 4 ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 5 ASIA PACIFIC ORAL MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 ASIA PACIFIC ORAL MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 ASIA PACIFIC INJECTABLE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 ASIA PACIFIC INJECTABLE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 ASIA PACIFIC OTHER ROUTE OF ADMINISTRATION MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 ASIA PACIFIC OTHER ROUTE OF ADMINISTRATION MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 12 ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 13 ASIA PACIFIC BISPHOSPHONATES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 ASIA PACIFIC BISPHOSPHONATES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 ASIA PACIFIC RANK LIGAND INHIBITORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 ASIA PACIFIC RANK LIGAND INHIBITORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 ASIA PACIFIC PARATHYROID HORMONE THERAPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 ASIA PACIFIC PARATHYROID HORMONE THERAPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 ASIA PACIFIC CALCITONIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 ASIA PACIFIC CALCITONIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 ASIA PACIFIC OTHER DRUG CLASS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 ASIA PACIFIC OTHER DRUG CLASS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 CHINA OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 26 CHINA OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 27 CHINA OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 28 CHINA OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 29 CHINA OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 30 CHINA OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 31 INDIA OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 32 INDIA OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 33 INDIA OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 34 INDIA OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 35 INDIA OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 36 INDIA OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 37 JAPAN OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 38 JAPAN OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 39 JAPAN OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 40 JAPAN OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 41 JAPAN OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 42 JAPAN OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 43 SOUTH KOREA OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 44 SOUTH KOREA OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 45 SOUTH KOREA OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 46 SOUTH KOREA OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 47 SOUTH KOREA OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 48 SOUTH KOREA OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 49 SINGAPORE OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 50 SINGAPORE OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 51 SINGAPORE OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 52 SINGAPORE OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 53 SINGAPORE OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 54 SINGAPORE OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 55 MALAYSIA OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 56 MALAYSIA OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 57 MALAYSIA OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 58 MALAYSIA OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 59 MALAYSIA OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 60 MALAYSIA OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 61 REST OF ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET, 2016 - 2019, USD MILLION
TABLE 62 REST OF ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET, 2020 - 2026, USD MILLION
TABLE 63 REST OF ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2016 - 2019, USD MILLION
TABLE 64 REST OF ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET BY ROUTE OF ADMINISTRATION, 2020 - 2026, USD MILLION
TABLE 65 REST OF ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2016 - 2019, USD MILLION
TABLE 66 REST OF ASIA PACIFIC OSTEOPOROSIS DRUGS MARKET BY DRUG CLASS, 2020 - 2026, USD MILLION
TABLE 67 KEY INFORMATION – AMGEN, INC.
TABLE 68 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 69 KEY INFORMATION – GLAXOSMITHKLINE PLC (GSK)
TABLE 70 KEY INFORMATION - MERCK & CO., INC.
TABLE 71 KEY INFORMATION – NOVARTIS AG
TABLE 72 KEY INFORMATION – PFIZER, INC.
TABLE 73 KEY INFORMATION – SUN PHARMACEUTICAL INDUSTRIES LTD.
TABLE 74 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 75 KEY INFORMATION – ALLERGAN PLC
TABLE 76 KEY INFORMATION – ELI LILLY AND COMPANY

LIST OF FIGURES

FIG 1 METHODOLOGY FOR THE RESEARCH